Filtern
Volltext vorhanden
- ja (9)
Gehört zur Bibliographie
- ja (9)
Dokumenttyp
Sprache
- Englisch (9)
Schlagworte
- multiple myeloma (7)
- medicine (3)
- CXCR4 (2)
- FDG (2)
- PET (2)
- lenalidomide (2)
- pomalidomide (2)
- theranostics (2)
- CD319 (1)
- CMV (1)
- CMV-specific cellular immunity (1)
- CS1 (1)
- Hepatitis B virus reactivation (1)
- IFN-γ ELISpot (1)
- PET/CT (1)
- SLAMF7 (1)
- T cells (1)
- \(^{11}\)C-methionine (1)
- antigen loss (1)
- antigen processing and presentation (1)
- artificial intelligence (1)
- bortezomib (1)
- combination therapy (1)
- elotuzumab (1)
- extramedullary disease (1)
- hematopoietic stem cell transplantation (1)
- immune monitoring (1)
- immunosuppression (1)
- induction regimen (1)
- kidney (1)
- molecular imaging (1)
- monoclonal antibody (1)
- natural language processing (1)
- ontology (1)
- peptide (1)
- plasma cells (1)
- radionuclide therapy (1)
- real world evidence (1)
- recall antigen (1)
- renal failure (1)
Cytomegalovirus (CMV) infection is a major cause of morbidity and mortality following hematopoietic stem cell transplantation (HSCT). Measuring CMV-specific cellular immunity may improve the risk stratification and management of patients. IFN-γ ELISpot assays, based on the stimulation of peripheral blood mononuclear cells with CMV pp65 and IE-1 proteins or peptides, have been validated in clinical settings. However, it remains unclear to which extend the T-cell response to synthetic peptides reflect that mediated by full-length proteins processed by antigen-presenting cells. We compared the stimulating ability of pp65 and IE-1 proteins and corresponding overlapping peptides in 16 HSCT recipients using a standardized IFN-γ ELISpot assay. Paired qualitative test results showed an overall 74.4% concordance. Discordant results were mainly due to low-response tests, with one exception. One patient with early CMV reactivation and graft-versus-host disease, sustained CMV DNAemia and high CD8\(^+\) counts showed successive negative protein-based ELISpot results but a high and sustained response to IE-1 peptides. Our results suggest that the response to exogenous proteins, which involves their uptake and processing by antigen-presenting cells, more closely reflects the physiological response to CMV infection, while the response to exogenous peptides may lead to artificial in vitro T-cell responses, especially in strongly immunosuppressed patients.